{
    "eid": "2-s2.0-85098653523",
    "title": "Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anticoagulation",
        "bleeding",
        "COVID-19",
        "thrombosis"
    ],
    "authors": [
        "Rushad Patell",
        "Thita Chiasakul",
        "Ethan Bauer",
        "Jeffrey I. Zwicker"
    ],
    "citedby-count": 41,
    "ref-count": 67,
    "ref-list": [
        "COVID-19 and its implications for thrombosis and anticoagulation",
        "Endothelial cell infection and endotheliitis in COVID-19",
        "Coagulopathy in COVID-19",
        "Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy",
        "Hypercoagulation and antithrombotic treatment in coronavirus 2019: A new challenge",
        "Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis",
        "Large-vessel stroke as a presenting feature of Covid-19 in the young",
        "Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels",
        "COVID and coagulation: Bleeding and thrombotic manifestations of SARS-CoV2 infection",
        "Deep vein thrombosis in hospitalized patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: Prevalence, risk factors, and outcome",
        "Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology [in Spanish]",
        "COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review",
        "ISTH interim guidance on recognition and management of coagulopathy in COVID-19",
        "Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?",
        "Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: A consensus statement before guidelines",
        "Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: An expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society",
        "SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection",
        "Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology",
        "Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: Position paper from VAS-European Independent Foundation in Angiology/Vascular Medicine",
        "Emergence of institutional antithrombotic protocols for coronavirus 2019",
        "Variability in institutional guidance for COVID-19-associated coagulopathy in the United States",
        "Methodological index for non-randomized studies (minors): Development and validation of a new instrument",
        "Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis",
        "Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)",
        "Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study",
        "COVID-19 and coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2 infection",
        "Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: Incidence and role of D-dimer as predictive factors",
        "Pulmonary embolism in patients with COVID-19 pneumonia",
        "DVT incidence and risk factors in critically ill patients with COVID-19",
        "Utility of D-dimer for diagnosis of deep vein thrombosis in coronavirus disease-19 infection",
        "Venous thromboembolism in SARS-CoV-2 patients: Only a problem in ventilated ICU patients, or is there more to it?",
        "Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia",
        "Pulmonary embolism in COVID-19 patients: A French multicentre cohort study",
        "Systematic screening for venous thromboembolic events in COVID-19 pneumonia",
        "Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019",
        "High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients",
        "Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy",
        "Comparison of venous thromboembolism risks between COVID-19 pneumonia and community-acquired pneumonia patients",
        "Incidence of venous thromboembolism in hospitalized patients with COVID-19",
        "VTE in ICU patients with COVID-19",
        "The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience",
        "Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan",
        "Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis",
        "Thrombotic events in SARS-CoV-2 patients: An urgent call for ultrasound screening",
        "Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom",
        "COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes",
        "Spontaneous echo contrast in venous ultrasound of severe COVID-19 patients",
        "Thrombotic complications and anticoagulation in COVID-19 pneumonia: A New York City hospital experience",
        "High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards",
        "Safety of intermediate dose of low molecular weight heparin in COVID-19 patients",
        "Preliminary experience with low molecular weight heparin strategy in COVID-19 patients",
        "Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg",
        "Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19",
        "Prophylactic anticoagulants for people hospitalised with COVID-19",
        "Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis",
        "Anticoagulation practice patterns in COVID-19: A global survey",
        "Rivaroxaban for thromboprophylaxis in acutely ill medical patients",
        "Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients",
        "A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients",
        "Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors",
        "Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: A systematic review and meta-analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Tel Aviv-Yafo",
            "@id": "60005681",
            "affilname": "Tel Aviv University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005681",
            "affiliation-country": "Israel"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60002746",
            "affilname": "Harvard Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002746",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}